Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Zhejiang Hisun Pharmaceutical Co Ltd
Operating Income
Zhejiang Hisun Pharmaceutical Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Z
|
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
|
Operating Income
¥1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Income
¥787.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
See Also
What is Zhejiang Hisun Pharmaceutical Co Ltd's Operating Income?
Operating Income
1B
CNY
Based on the financial report for Sep 30, 2023, Zhejiang Hisun Pharmaceutical Co Ltd's Operating Income amounts to 1B CNY.
What is Zhejiang Hisun Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
6%
Over the last year, the Operating Income growth was -1%.